LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Restaurants for Sale
Furniture & Home Decor Businesses for Sale
Environmental Businesses for Sale
Finance & Accounting Businesses for Sale
Manufacturing Businesses for Sale
Convenience Stores & Lotto Businesses For Sale
Construction & Landscaping Businesses for Sale
Wholesale & Distribution Businesses for Sale
Pet Businesses for Sale
Banquet Halls & Catering Businesses for Sale
Child Care & Education Franchise Opportunities
Smoke & Vape Shop Franchises for Sale
Wholesale & Distribution Franchise Opportunities
Liquor Franchises for Sale
Hotel & Motel Franchises for Sale
Clothing & Shoe Store Franchise Opportunities
Beauty & Personal Care Franchises for Sale
Employment & Personnel Franchise Opportunities
Automotive Franchises for Sale
Senior Care Franchise for Sale
Warehouses for Sale or Lease
Plazas for Sale
Medical Buildings for Sale or Lease
Office Spaces for Sale or Rent
Commercial Buildings for Sale or Lease
Office Buildings for Sale or Rent
Industrial Buildings for Sale or Lease
Houses & Condos for Sale or Lease
Miscellaneous Properties for Sale or Lease
Medical Office Spaces for Sale or Rent
An email will be sent to registered email address.
Please select if you are: